1Liaw YF,Tsai SL. Pathogenesis and clinical significance of acute exacerbation and remissions in patients with chronic hepatitis B virus infection. Viral Hep Rev,1997,3:143 - 154
2Zoulim F,Trepo C.Drug therapy for chronic hepatitis B:antiviral effecacy and influence of hepatitis B Virus polymerase mutations on the outcome of therapy. J Hepatol,1998,29(1):151 - 168
3Liaw YF.Acute exacerbation and superinfection in patients with chronic viral hepatitis. J Formos Med Assoc, 1995,94(9) :521 - 528
4Liaw YF, Chein RN, Yeh CT, et al. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology, 1999,30(2) :567 - 572
5Lin SH,Sheen IS,Chien RN,et al.Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology, 1999,29:971 - 975
6Dusheiko G. Side effect of alpha interferon in chronic hepatitis C. Hepatology, 1997,26(3 Suppl 1): 112S - 121S
7Chien RN,Liaw YF and Atkins M.Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with hepatitis B. Hepatology, 1999,30(3) :770 - 774
8Shaw T,Mok SS and Locarini SA.Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibiton of HBV replication by penciclovir. Hepatology, 1996,24(5) :996-1002
9Chien RN, Liaw YF, Chen TC,et al. Efficacy of thymosin-α1 in patients with chronic hepatitis B: a randomized, controlled trial. Hepatology, 1998,27(5): 1383 - 1387
10Fontana RJ and Lok ASF. Combination therapy for chinic hepatitis B.Hepatology, 1997,26 ( 1 ): 234 - 237
